|
|
| Line 661: |
Line 661: |
|
| |
|
| ='''Suggestions to Add to This Page'''= | | ='''Suggestions to Add to This Page'''= |
|
| |
| ===2022: [https://pubmed.ncbi.nlm.nih.gov/35869375/ Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV]===
| |
|
| |
| ===2022: [https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-14341-z Population-level counterfactual trend modelling to examine the relationship between smoking prevalence and e-cigarette use among US adults]===
| |
|
| |
|
| ===2022: [https://tobaccocontrol.bmj.com/content/31/e1/e10 Association of device type, flavours and vaping behaviour with tobacco product transitions among adult electronic cigarette users in the USA]=== | | ===2022: [https://tobaccocontrol.bmj.com/content/31/e1/e10 Association of device type, flavours and vaping behaviour with tobacco product transitions among adult electronic cigarette users in the USA]=== |